KJ Bio A/S: Financial statements 2022
CVR: 40352104
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
KJ Bio A/S (CVR 40352104) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -122,538 and a net result of DKK -525,745. Equity in the 2022 report amounted to DKK 58,810. The solvency ratio was 30.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -122,538
- Profit/Loss
- DKK -525,745
- Equity
- DKK 58,810
- Total Assets
- DKK 193,774
- Employees
- 1
Official annual report
Keep an eye on KJ Bio A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout KJ Bio A/S
KJ Bio A/S was a Danish company of the type Aktieselskab based in Hinnerup, founded in 2019. The company has been dissolved on 29 April 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named TGOD Genetics A/S. The company has 1 employee (2023). In 2024, the company reported a gross profit of DKK -51,660 and a net result of DKK -106,521 compared with DKK -559,828 the year before. Equity in the 2024 report amounted to DKK -607,539.